Point72 Asset Management
BNTX icon

Point72 Asset Management’s BioNTech BNTX Stock Holding History

Point72 Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.4M Buy
+327,184
New +$30.8M 0.03% 649
2024
Q4 		– Sell
-361,993
Closed -$43M – 2093
2024
Q3 		$43M Sell
361,993
-99,718
-22% -$9.17M 0.11% 217
2024
Q2 		$37.1M Buy
461,711
+341,311
+283% +$31.2M 0.1% 276
2024
Q1 		$11.1M Buy
+120,400
New +$11.5M 0.03% 678
2023
Q1 		– Sell
-302,600
Closed -$45.5M – 2245
2022
Q4 		$45.5M Buy
302,600
+192,600
+175% +$29.6M 0.15% 175
2022
Q3 		$14.8M Buy
+110,000
New +$16.8M 0.06% 400
2022
Q1 		– Sell
-88,700
Closed -$22.9M – 1181
2021
Q4 		$22.9M Buy
+88,700
New +$24.3M 0.09% 304

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Point72 Asset Management's BNTX Position: Q2 2026 in Review

Point72 Asset Management opened a new position in BioNTech (BNTX) in Q2 2026: 327,184 shares worth $30.4M. The stake represents 0.03% of the portfolio and ranks #649 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in BNTX as recently as Q3 2024.

Point72 Asset Management first reported a position in BNTX in Q4 2021 and has held it in 7 quarters since. The position peaked at $45.5M in Q4 2022. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Point72 Asset Management held 327,184 shares of BioNTech worth $30.4M as of Q2 2026.
  • BioNTech was a new Point72 Asset Management position in Q2 2026.
  • BioNTech made up 0.03% of Point72 Asset Management's portfolio in Q2 2026, its #649 holding.
  • Point72 Asset Management first reported a position in BioNTech in Q4 2021 and has held it in 7 quarters since.
  • Point72 Asset Management's BioNTech position peaked at $45.5M in Q4 2022.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.